Azevedo RS, Braish J, Gener-Ricos G, Tang G, et al. Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia. Leuk Lymphoma 2025 Oct 31:1-5. doi: 10.1080/10428194.2025.2568745.
PMID: 41173347